Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,265,142
-
Share change
-
+3,811,804
-
Total reported value
-
$55,444,000
-
Price per share
-
$8.85
-
Number of holders
-
45
-
Value change
-
+$33,732,000
-
Number of buys
-
44
Institutional Holders of OBALON THERAPEUTICS INC - COM (OBLN) as of Q4 2016
As of 31 Dec 2016,
OBALON THERAPEUTICS INC - COM (OBLN) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,265,142 shares.
The largest 10 holders included
INTERWEST VENTURE MANAGEMENT CO, Tamarack Advisers, LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, KORNITZER CAPITAL MANAGEMENT INC /KS, MILLENNIUM MANAGEMENT LLC, PEREGRINE CAPITAL MANAGEMENT LLC, WASATCH ADVISORS INC, Pier Capital, LLC, WADDELL & REED FINANCIAL INC, and VANGUARD GROUP INC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.